A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor

Inclusion Criteria: * 18 years old ≤age≤65 years of age,male. * Hemophilia A or B patients with inhibitors. * Peak historical inhibitor titer ≥ 5 BU and a positive inhibitor test when enrolled. * Establish proper venous access. * Provide signed informed consent. Exclusion Criteria: * Have any coagulation disorder other than hemophilia A or B. * Treat with prophylactic treatment of coagulation factor. * Treat with anticoagulant within 7d of the time of study drug administration. * Have an active, ongoing bleeding for which the patient is being treated, or treatment for a bleeding was stopped within 7d of the time of study drug administration. * Have a history of arterial and/or venous thromboembolic events. * Have platelet count \<100,000/mL. * Severe liver or kidney disease. * Accept major operation or blood transfusion within 1 month of the time of screening. * HIV antibody positive. * Have a known allergy to Blood product. * Participate in other clinical research within 1 month of the time of study drug administration.